---
figid: PMC6478395__nihms-755940-f0003
figlink: /pmc/articles/PMC6478395/figure/F3/
number: F3
caption: Oncogenic mutations in the BRAF gene lead to constitutive signaling down
  the MAPK pathway leading to multiple deleterious effects, including tumor cell proliferation,
  angiogenesis, invasion and metastasis, and resistance to apoptosis. Importantly,
  this can also lead to immune evasion, and immunogenicity may be increased through
  treatment with BRAF inhibitors.
pmcid: PMC6478395
papertitle: Targeted Therapies Combined with Immune Checkpoint Therapy.
reftext: Peter A. Prieto, et al. Cancer J. 2016 Mar-Apr;22(2):138-146.
pmc_ranked_result_index: '92097'
pathway_score: 0.8883984
filename: nihms-755940-f0003.jpg
figtitle: BRAF mutations on tumor cell survival and the tumor microenvironment
year: '2016'
organisms:
- Homo sapiens
ndex: 04d64959-de9f-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6478395__nihms-755940-f0003.html
  '@type': Dataset
  description: Oncogenic mutations in the BRAF gene lead to constitutive signaling
    down the MAPK pathway leading to multiple deleterious effects, including tumor
    cell proliferation, angiogenesis, invasion and metastasis, and resistance to apoptosis.
    Importantly, this can also lead to immune evasion, and immunogenicity may be increased
    through treatment with BRAF inhibitors.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAP2K1
  - MAP2K2
  - MAPK3
  - AKT3
  - AKT1
  - MAPK1
  - RAF1
  - PIK3R3
  - PIK3CD
  - MTOR
  - NRAS
  - PIK3CG
  - PTEN
  - PIK3R6
  - PIK3CB
  - PIK3R5
  - PIK3R4
  - RORC
  - KIT
  - PIK3CA
  - BRAF
  - AKT2
  - Cancer
  - Lung cancer
genes:
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: CRAF
  symbol: c-Raf
  source: hgnc_alias_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: (mTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: NRAS
  symbol: NRAS
  source: hgnc_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: TOR
  symbol: TOR
  source: hgnc_alias_symbol
  hgnc_symbol: RORC
  entrez: '6097'
- word: c-Kit
  symbol: C-Kit
  source: hgnc_alias_symbol
  hgnc_symbol: KIT
  entrez: '3815'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
figid_alias: PMC6478395__F3
redirect_from: /figures/PMC6478395__F3
figtype: Figure
---
